Curanex Pharmaceuticals Inc — Form 8-K
Filed October 19, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Curanex Pharmaceuticals Inc (total assets ~$5.1M) filed an 8-K on 2026-10-19 for period ending 2026-09-14 disclosing Item 8.01 (Other Events). The filing contains no narrative detail in the extracted text—only document metadata and XBRL formatting files are shown. No counterparties, dollar amounts, share counts, dates of material transactions, or substantive business developments are disclosed in the filing extract provided.
Why this rating
Filing contains no material event disclosure; appears to be empty Item 8.01 or boilerplate submission. Routine administrative filing.
Extracted items
See more from October 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.